GlaxoSmithKline Consumer Healthcare on Monday posted little over ten per cent growth in net profit at Rs 59 crore in the fourth quarter ending December 31.
The company which follows calendar year, reported 19 per cent increase in sales at Rs 602 crore in the reporting quarter with profits before tax of Rs 97 crore recording a growth of 22 percent. The net profit in Q4 2011 stood at Rs 59 crore against Rs 53.37 crore in the corresponding period, a company statement said.
The company said its net profit has gone up by 18 percent at Rs 355 crore for the year ended December 31, 2011 while net sales increased by 16 percent at Rs 2,686 crore for the year ended December 31, 2011.
The board of directors of the company has recommended a dividend at the rate of Rs 35 per equity share of Rs 10 each for the year.
Commenting on the results, managing director of the company Mr Zubair Ahmed said, “GSK is able to record strong topline growth by leveraging science and innovation, quarter after quarter. Further insight-based communication coupled with increased penetration across categories helped the company to record strong growth across brands.”
He also said that despite high inflation in commodities, cost engineering program helped the company deliver superior results.